By Josh White
Date: Tuesday 02 Jan 2024
LONDON (ShareCast) - (Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.
The AIM-traded firm said that as a result, investors would be issued 3,093,915 warrants, representing 40% of the drawdown's value divided by the reference price of 7.7572p.
It said the warrants would have an exercise price of 140% of the reference price, equating to 10.86p.
At 1336 GMT, shares in Genedrive were down 0.92% at 8.05p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 2.45p |
Change Today | 0.050p |
% Change | 2.08 % |
52 Week High | 9.50p |
52 Week Low | 1.45p |
Volume | 18,419,832 |
Shares Issued | 543.14m |
Market Cap | £13.31m |
Beta | 1.12 |
RiskGrade | 747 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:19 | 3,000,000 @ 2.50p |
16:28 | 50,000 @ 2.40p |
16:18 | 9,828 @ 2.41p |
16:17 | 83,160 @ 2.41p |
16:06 | 7,000 @ 2.41p |
You are here: research